Neff, T., Jungheinrich, C., Doelberg, M., Sauerland, A., Spahn, D., & Stocker, R. (2001). Advantages of 6% hydroxyethyl starch 130/0.4 (Voluven(®)) at repetitive high dose levels in patients with severe cranio-cerebral trauma. BioMed Central.
Citação norma ChicagoNeff, ThA, C. Jungheinrich, M. Doelberg, A. Sauerland, DR Spahn, and R. Stocker. Advantages of 6% Hydroxyethyl Starch 130/0.4 (Voluven(®)) At Repetitive High Dose Levels in Patients With Severe Cranio-cerebral Trauma. BioMed Central, 2001.
Citação norma MLANeff, ThA, et al. Advantages of 6% Hydroxyethyl Starch 130/0.4 (Voluven(®)) At Repetitive High Dose Levels in Patients With Severe Cranio-cerebral Trauma. BioMed Central, 2001.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.